CorMedix Inc. (CRMD)

CorMedix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	256.69	144.84	40.65	43.64	43.15	53.32
Short-Term Investments	-	3.69	11.04	32.39	15.64	12.15
Cash & Short-Term Investments	256.69	148.53	51.69	76.03	58.79	65.47
Cash Growth	34.60%	187.36%	-32.02%	29.32%	-10.20%	41.24%
Receivables	161.31	171.23	51.65	-	-	0.05
Inventory	38.58	29.72	7.6	2.11	-	0
Prepaid Expenses	23.32	16.92	3.63	0.76	0.62	0.77
Restricted Cash	0.66	0.66	-	0.08	0.12	0.13
Other Current Assets	-	-	-	0.47	0.01	0.05
Total Current Assets	480.55	367.05	114.58	79.45	59.55	66.47
Property, Plant & Equipment	7.85	9.93	2.32	2.51	2.38	2.37
Long-Term Investments	-	10.36	-	-	-	-
Goodwill	30	30	-	-	-	-
Other Intangible Assets	358.47	379.07	1.84	-	-	-
Long-Term Deferred Tax Assets	-	16.28	-	-	-	-
Other Long-Term Assets	27.17	13.45	0.11	0.1	0.1	0.1
Total Assets	904.05	826.14	118.85	82.06	62.04	68.95

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	10.24	7.88	1.72	4.28	2.2	2.21
Accrued Expenses	160.19	148.36	29.95	6.97	3.97	3.01
Current Portion of Leases	-	1.45	0.17	0.15	0.13	0.12
Current Income Taxes Payable	13.05	12.76	-	-	-	-
Other Current Liabilities	3.91	3.82	2	-	-	-
Total Current Liabilities	187.4	174.27	33.84	11.4	6.31	5.35
Long-Term Debt	145.15	144.63	-	-	-	-
Long-Term Leases	2.31	2.84	0.35	0.52	0.67	0.8
Other Long-Term Liabilities	107.71	99.1	-	-	-	-
Total Liabilities	443.22	420.84	34.19	11.92	6.98	6.15

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.08	0.08	0.06	0.05	0.04	0.04
Additional Paid-In Capital	572.74	581.8	424.13	391.69	330.29	308.33
Retained Earnings	-111.99	-176.58	-339.63	-321.7	-275.36	-245.66
Comprehensive Income & Other	0	0	0.09	0.09	0.08	0.09
Total Common Equity	460.83	405.31	84.66	70.14	55.06	62.8
Shareholders' Equity	460.83	405.31	84.66	70.14	55.06	62.8
Total Liabilities & Equity	904.05	826.14	118.85	82.06	62.04	68.95

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	147.46	148.91	0.52	0.67	0.8	0.92
Net Cash (Debt)	109.24	9.98	51.17	75.36	57.99	64.54
Net Cash Growth	-42.59%	-80.50%	-32.10%	29.96%	-10.15%	42.43%
Net Cash Per Share	1.20	0.12	0.87	1.48	1.44	1.71
Filing Date Shares Outstanding	77.94	79.05	65.18	54.98	44.48	38.71
Total Common Shares Outstanding	77.67	79.26	64.41	54.94	42.79	38.06
Working Capital	293.16	192.78	80.74	68.05	53.24	61.12
Book Value Per Share	5.93	5.11	1.31	1.28	1.29	1.65
Tangible Book Value	72.36	-3.77	82.81	70.14	55.06	62.8
Tangible Book Value Per Share	0.93	-0.05	1.29	1.28	1.29	1.65

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 30, 2026

Data Sources Report a data error